Notifications Bell

Walgreens posted mixed quarterly earnings

Walgreens posted mixed quarterly earnings

Profit fell less than forecasted

One of the largest pharma chains in the US, Walgreens had its financial report. The figures came in mixed.

The quarterly profit fell less than expected to $373 million, or 43 cents per share. The last year’s figures were $677 million. The EPS decreased to $1.02, but it topped the 96 cents consensus.

Walgreens sales rose 2.3% to $34.75 billion. The market was looking for $34.37 billion. At a US level, sales increased 3.6% to $27 billion.

At a global level, sales dropped 14.9% to $2.3 billion. However, the figures came in higher than the $2.2 billion expected.

For the future, Walgreen expects strong EPS growth.

Following the news, Walgreen stock price gained almost 3%. Year-to-date, the stock dropped 39%.


This information prepared by is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of

JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.